The Crystal Structure of Human Soluble CD14 Reveals a Bent Solenoid with a Hydrophobic Amino-Terminal Pocket
暂无分享,去创建一个
[1] J. Silver,et al. Biochemistry and expression of myelomonocytic antigens. , 1986, Journal of immunology.
[2] S. Akira,et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.
[3] T. Kirkland,et al. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor , 1996, Infection and immunity.
[4] F. Re,et al. Specific High Affinity Interactions of Monomeric Endotoxin·Protein Complexes with Toll-like Receptor 4 Ectodomain* , 2007, Journal of Biological Chemistry.
[5] A. McPherson,et al. Current approaches to macromolecular crystallization. , 1990, European journal of biochemistry.
[6] Masakatsu Kamiya,et al. Structural principles of leucine‐rich repeat (LRR) proteins , 2003, Proteins.
[7] F. Peri,et al. A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity , 2012, ChemMedChem.
[8] R. Menzel,et al. Structures in Bacillus subtilis Are Recognized by CD14 in a Lipopolysaccharide Binding Protein-Dependent Reaction , 1999, Infection and Immunity.
[9] D. Golenbock,et al. Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.
[10] S. Nomura,et al. Purification and characterization of human soluble CD14 expressed in Pichia pastoris. , 2003, Protein expression and purification.
[11] D L Simmons,et al. Monocyte antigen CD14 is a phospholipid anchored membrane protein. , 1989, Blood.
[12] Anil Verma,et al. Lysine Methylation as a Routine Rescue Strategy for Protein Crystallization , 2006, Structure.
[13] S. Goyert,et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.
[14] Jennifer L. Martin,et al. Post-crystallization treatments for improving diffraction quality of protein crystals. , 2005, Acta crystallographica. Section D, Biological crystallography.
[15] S. Wright,et al. Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein , 1996, The Journal of Biological Chemistry.
[16] R. Jerala,et al. Expression and refolding of functional fragments of the human lipopolysaccharide receptor CD14 in Escherichia coli and Pichia pastoris. , 1999, Protein expression and purification.
[17] A. Kallies,et al. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. , 1996, Journal of immunology.
[18] J. Mathison,et al. Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide* , 2000, The Journal of Biological Chemistry.
[19] A. McMichael. Leucocyte typing III : white cell differentiation antigens , 1987 .
[20] Roger L. Williams,et al. The effects of neutral detergents on the crystallization of soluble proteins , 1986 .
[21] A. McPherson. Use of polyethylene glycol in the crystallization of macromolecules. , 1985, Methods in Enzymology.
[22] R. Ulevitch,et al. Structure and function of lipopolysaccharide binding protein. , 1990, Science.
[23] M. L. Le Beau,et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. , 1988, Science.
[24] Hayyoung Lee,et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.
[25] G. Vereb,et al. Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils. , 2012, Immunology letters.
[26] M. S. Rangel-Frausto. Sepsis: still going strong. , 2005, Archives of medical research.
[27] R. Ulevitch,et al. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.
[28] Hayyoung Lee,et al. Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.
[29] S. Goyert,et al. Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. , 1988, Nucleic acids research.
[30] Y. Satow,et al. Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.
[31] Sung-Hou Kim,et al. Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .
[32] M. Wurfel,et al. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. , 1997, Journal of immunology.
[33] B. Lorber,et al. Additives for the crystallization of proteins and nucleic acids , 1999 .
[34] R. Menzel,et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. , 1997, European journal of biochemistry.
[35] T. Kirkland,et al. CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.
[36] R. Salomão,et al. Bacterial Sensing, Cell Signaling, and Modulation of the Immune Response During Sepsis , 2012, Shock.
[37] Zaida Luthey-Schulten,et al. MultiSeq: unifying sequence and structure data for evolutionary analysis , 2006, BMC Bioinformatics.
[38] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[39] J. Thornton,et al. Helix geometry in proteins. , 1988, Journal of molecular biology.
[40] M. Wurfel,et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.
[41] D. Golenbock,et al. The Differential Impact of Disulfide Bonds and N-Linked Glycosylation on the Stability and Function of CD14* , 2008, Journal of Biological Chemistry.
[42] M. Brenner. Leucocyte Typing III. White Cell Differentiation Antigens , 1988 .
[43] T. Kirkland,et al. A Region of Human CD14 Required for Lipopolysaccharide Binding (*) , 1995, The Journal of Biological Chemistry.
[44] B. Costa,et al. Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. , 2009, Journal of medicinal chemistry.
[45] S. Paik,et al. Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling*♦ , 2005, Journal of Biological Chemistry.
[46] R. Munford,et al. Endotoxin-binding Proteins Modulate the Susceptibility of Bacterial Endotoxin to Deacylation by Acyloxyacyl Hydrolase* , 2007, Journal of Biological Chemistry.
[47] Song Jiang,et al. Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling , 2010, The Journal of Immunology.
[48] Hidehiko Sano,et al. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll‐like receptors 2 and 1 without binding to the complex , 2006, Cellular microbiology.
[49] J. Gegner,et al. Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.
[50] J. Weiss,et al. Isolation of Monomeric and Dimeric Secreted MD-2 , 2008, Journal of Biological Chemistry.
[51] S. Opal,et al. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? , 1999, Critical care medicine.
[52] R. Tapping,et al. Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.
[53] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] J. Bajorath,et al. Identification of CD14 residues involved in specific lipopolysaccharide recognition , 1997, Infection and immunity.
[55] G. Núñez,et al. ML -- a conserved domain involved in innate immunity and lipid metabolism. , 2002, Trends in biochemical sciences.
[56] R. Ulevitch,et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. Narhi,et al. CD14: Physical Properties and Identification of an Exposed Site That Is Protected by Lipopolysaccharide (*) , 1995, The Journal of Biological Chemistry.
[58] N. Gay,et al. A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins , 2007, PloS one.
[59] J. Weiss,et al. Transfer of Monomeric Endotoxin from MD-2 to CD14 , 2007, Journal of Biological Chemistry.
[60] J. Silver,et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. , 1996, Immunity.
[61] Liping Yu,et al. Evidence of a specific interaction between new synthetic antisepsis agents and CD14. , 2009, Biochemistry.
[62] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[63] Thomas C. Mitchell,et al. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.
[64] L. Kline,et al. Phagocytosis of Gram‐negative bacteria by a unique CD14‐dependent mechanism , 1997, Journal of leukocyte biology.
[65] S. Wright,et al. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. , 1997, The Journal of clinical investigation.
[66] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[67] D. Golenbock,et al. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. , 1996, Journal of immunology.
[68] M. Kelley,et al. Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (*) , 1995, The Journal of Biological Chemistry.
[69] R. Jack,et al. Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteria , 1995, European journal of immunology.
[70] M. Koch,et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. , 2000, European journal of biochemistry.
[71] R. Kim,et al. Optimum solubility (OS) screening: an efficient method to optimize buffer conditions for homogeneity and crystallization of proteins. , 2004, Acta crystallographica. Section D, Biological crystallography.
[72] M. Kelley,et al. Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding (*) , 1995, The Journal of Biological Chemistry.
[73] Koichi Fukase,et al. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 , 2012, Proceedings of the National Academy of Sciences.
[74] Thomas E. Creighton,et al. Stability of alpha-helices , 1987, Nature.
[75] R. Tapping,et al. Cellular Binding of Soluble CD14 Requires Lipopolysaccharide (LPS) and LPS-binding Protein* , 1997, The Journal of Biological Chemistry.
[76] Elspeth Garman,et al. 'Cool' crystals: macromolecular cryocrystallography and radiation damage. , 2003, Current opinion in structural biology.
[77] A. Tomasz,et al. CD14 is a pattern recognition receptor. , 1994, Immunity.
[78] David A. Johnson,et al. Soluble CD14 Truncated at Amino Acid 152 Binds Lipopolysaccharide (LPS) and Enables Cellular Response to LPS (*) , 1995, The Journal of Biological Chemistry.
[79] D. Golenbock,et al. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.
[80] M. Volta,et al. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. , 1998, Journal of immunology.
[81] K. Fukase,et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. , 2001, International immunology.
[82] H. Engelmann,et al. The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. , 1996, European journal of biochemistry.
[83] J. Elder,et al. Endoglycosidases from Flavobacterium meningosepticum application to biological problems. , 1989, Methods in enzymology.
[84] J. Silver,et al. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. , 1994, Journal of immunology.
[85] R. Tapping,et al. Soluble CD14-mediated cellular responses to lipopolysaccharide. , 2000, Chemical immunology.
[86] H. Northoff,et al. Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. , 1998, Infection and immunity.
[87] B. Lindner,et al. Newer aspects of the chemical structure and biological activity of bacterial endotoxins. , 1985, Progress in clinical and biological research.
[88] N. Coussens,et al. Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[89] C. Whitfield,et al. Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.
[90] L. Kremer,et al. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS‐binding protein , 2007, FEBS letters.
[91] Bin Chen,et al. Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. , 2008, Biochemical and biophysical research communications.
[92] Elliott Bennett-Guerrero,et al. Structure and function of lipopolysaccharides. , 2002, Microbes and infection.
[93] V. Lopez,et al. Purification of soluble CD14 fusion proteins and use in an electrochemiluminescent assay for lipopolysaccharide binding. , 2007, Protein expression and purification.
[94] D. Rossignol,et al. Inhibition of endotoxin response by synthetic TLR4 antagonists. , 2004, Current topics in medicinal chemistry.
[95] M. Muroi,et al. Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa* , 2006, Journal of Biological Chemistry.
[96] Ping-yuan Wang,et al. Phosphatidylinositides Bind to Plasma Membrane CD14 and Can Prevent Monocyte Activation by Bacterial Lipopolysaccharide* , 1998, The Journal of Biological Chemistry.